ANGPT2 and colorectal cancer: For example, Volkova et al. analyzed Ang-2 of serum samples in colorectal cancer patients (n = 344) and confirmed serum Ang-2 as a significant predictor for outcome of colorectal cancer, as well as metastatic CRC treated with bevacizumab-containing therapy [18].